- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04161521
Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A descripative cohort study which included 60 pregnant women recuirted from Obstetrics and Gynecology Department, Menoufia University Hospital and diagnosed as placenta previa accreta.
• Ethical considerations: Ethics: The study was approved by Ethical Committee of Menoufia Faculty of Medicine.
Consent: after explanation of surgical procedure of the study, an informed written consent was obtained from all cases included in this study.
Sample size: (No= 60) Based on previous studies regarding MAP, The incidence of placenta accreta = 1/2500 , so the calculated sample size for this study was 59 which to be around 60 with confidence level 95% margin of error 5% (Pliskow S et al., 2009).
Inclusion criteria:
- Age between 20 - 40 years old.
- Gestational age between 28 - 38 weeks.
Any patient diagnosed as placenta previa with ultrasound criteria of accretion.
Criteria of accretion by Colour Doppler ultrasound include: (Berkley et al., 2013).
- The presence of irregular shaped placental lacunae within the placenta.
- Thinning of myometrium overlying the placenta.
- Absence of retroplacental 'non-lucent line'.
- Protrusion of the placenta into the bladder.
- Increased vascularity of the uterine serosa-bladder interface.
- Turbulent blood flow through the lacunae on Doppler ultrasonography.
- All patients were subjected to the following:
I. Detailed history taking:
- Personal history: name ,age, address, occupation, marietal status, number of children ,age of the youngest child, the gender of the children and special habbits of medical importance like smoking.
- Past history: past medical history (e.g. diabetes mellitus, hypertension, renal disease, liver disease and any systemic disease like cardiac or pulmonary diseases), past surgical history (any operation done before), blood transfusion, drugs taken and allergy from any drug.
- Family history: hypertension, diabetes mellitus, consanguinity.
- Menstrual history: LMP (the first day of last menstrual period), duration, frequency, regularity of period, presence of dysmenorrhea and EDD (the expected date of delivery).
- Obstetric history : gravidity, parity, number of deliveries, mode of delivery (normal vaginal delivery or cesarean delivery) , place of delivery, the reason for cesarean delivery, any operative complications, number of children and their gender , any neonatal complications, number of abortions, gestational age of them, if abortion followed by surgery like evacuation and curettage.
II. Clinical examination:
General examination:
- General condition.
- Vital signs including blood pressure, pulse, temperature.
- Height, weight and body mass index (BMI).
- Neck : thyroid gland, neck veins and pulsations.
- Chest : lung, heart, breasts.
- Upper and lower limbs (edema , varicosities).
Abdominal examination :
Inspection :
Size, shape, pigmentation (linea nigra),stria gravidarum and scars (like cesarean section scars).
Palpation:
To detect tenderness, rigidity and fundal level.
Auscultation:
Fetal heart sounds.
III. Investigations :
- Preoperative labaratory investigations like complete blood count (CBC), prothrombin time (PT), liver function, kidney function, virology and ECG.
- Obstetric ultrasound:
Fetal observation : transabdominal pelvic ultrasound was performed to detect fetal presentation, lie, viability ( by observation of fetal heart movement), gestational age by measuring biparital diameter, femur length and abdominal circumference) and fetal weight.
Placenta observation : site (anterior or posterior), position in realtion to internal os to determine type of placenta previa and colour Doppler to determine grade of accretion ( accrete, increta, percreta and focal aacretion) and criteria of accretion.
Surgical Procedure:
Uterine conservation required multidisciplinary team including the obstetrician, anasethetist and urologist in certain cases.
- Preoperative prophylactic antibiotic was given to study cases prior to skin incision tio avoid postoperative endometritis in the form of 2gm ampicillin. (ACOG, 2011)
- Preoperative blood cross matching as availability of adequate blood was mandatory.
Operative Steps:
- Elective CS at 36 weeks to 37 weeks was done.
- Prior to delivery, two large bore venous lines were placed.
- General anasethia was recommended.
- Foley catheter was inserted.
- Sterilization by povidone- iodine scrub and toweling.
- Midline incision was done as it made field obvious.
- Incision of subcutaneous tissue and rectus sheath.
- Separation of two recti.
- Classical CS (vertical incision in the upper uterine segment) or high transverse uterine incision was done to decrease haemorrhage through placental bed and to avoid urinary bladder injury as it may be adherent to lower uterine segment in some cases.
- Delievery of the fetus by gental fundal pressure.
- At the delivery of the fetus 10 UI of oxytocin IV was injected to help uterus to contract and avoid postpartum atony and to decrease blood loss during delivery.
- No attempt to the deliver the placenta
- Exteriorization of uterus including placenta clamped.
- Two corners of the uterine incision, and the superior and inferior lips, were clamped immediately by four clamps.
- Opening of the broad ligament via round ligament division and ligation.
- Gentle dissection of the bladder from the uterus was performed from lateral aspect to medially.
- Bilateral uterine artery clamping at below the placental bed
- Continue gentle dissection the remaining adherent part of the urinary bladder
- Gentle attempt to delierve the placenta by gentle traction on clamp.
- If the placenta was delievered, bilateral uterine artery ligation at multiple levels and multiple square compression sutures (if needed) to control pacental bleeding bed .
- If the placenta was not delievered we did segmental ressection of lower uterine segment including the placenta. The affected area, once excised can be repaired and the patient was treated as though she had a classical cesarean delivery.
- Intraperitoneal drain was inserted for early detection of intraperitoneal hemorrhage or urine leak in case of cystotomy repair or possible ureteric injury.
- The amount of blood loss within 24 h after surgery was measured by the weight of blood-soaked disposable hip pads minus its own weight.
- Transfusion must include not only packed red blood cells (PRBC), but also fresh frozen plasma and/or cryoprecipitate to maintain in a 2:1 ratio to prevent dillutional coagulopathy
Outcome variables:
- Demographic data e.g age, parity, body mass index (BMI).
- Amount of blood loss by measuring Hb preoperatively and after blood transfusion.
- Amount of blood loss intraoperative via amount and number of tampons used.
- Amount of blood and blood products transfusion.
- Hemeostasis and analegesia postoperatively.
- Duration of ambulation and audible intestinal sounds.
- Follow up of nishe at placental bed after 6 weeks via color Doppler Ultrasoumd.
- Intraoperative complications e.g urinary bladder injury, ureteric injury.
- Postoperative complications e.g ileus, sepsis.
- Need for conversion to hysterectomy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Shibīn Al Kawm, Egypt, 11111
- Hamed Elsayed Ellakwa
-
-
Menoufia
-
Shibīn Al Kawm, Menoufia, Egypt, 11111
- Menoufia university hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1- Age between 20 - 40 years old. 2- Gestational age between 28 - 38 weeks. 3- Any patient diagnosed as placenta previa with ultrasound criteria of accretion.
Criteria of accretion by Colour Doppler ultrasound include: (Berkley et al., 2013).
- The presence of irregular shaped placental lacunae within the placenta.
- Thinning of myometrium overlying the placenta.
- Absence of retroplacental 'non-lucent line'.
- Protrusion of the placenta into the bladder.
- Increased vascularity of the uterine serosa-bladder interface.
Turbulent blood flow through the lacunae on Doppler ultrasonography.
Exclusion Criteria:
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Placenta Accreta patients
of 60 pregnant female diagnosed as placenta previa accreta recuirted from Obstetrics and Gynecology Department , Menoufia University Hospital.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Outcome variables: Need for conversion to hysterectomy.
Time Frame: 30- 90 minutes
|
control of bleeding and need for removal of uterus.
|
30- 90 minutes
|
Blood Loss.
Time Frame: During operation and 24 hours postpartum.
|
Amount of blood loss ,Number of packed red blood cells and blood products transfusion.
|
During operation and 24 hours postpartum.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intraoperative complications
Time Frame: During operation and postpartum period.
|
urinary bladder injury, ureteric injury.
Postoperative complications e.g ileus, sepsis
|
During operation and postpartum period.
|
Collaborators and Investigators
Investigators
- Study Director: Hamed E Ellakwa, Menoufia
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Menoufia OGG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Placenta Accreta
-
Kasr El Aini HospitalUnknownPlacenta Accreta in Placenta Previa Anterior
-
Ain Shams Maternity HospitalCompleted
-
Maternal and Child Health Hospital of FoshanWithdrawnPlacenta Accreta SpectrumChina
-
Sohag UniversityRecruiting
-
Necmettin Erbakan UniversityRecruitingPlacenta Accreta, Third TrimesterTurkey
-
Ain Shams UniversityNot yet recruiting
-
Ain Shams UniversityUnknownPlacenta Accreta, Third TrimesterEgypt
-
HaEmek Medical Center, IsraelTechnion, Israel Institute of TechnologyUnknown
-
Hatem AbuHashimCompletedPlacenta Accreta SpectrumEgypt
-
Hatem AbuHashimUnknownPlacenta Accreta Spectrum
Clinical Trials on Novel Technique of Placenta Accreta in Menoufia University Hospital
-
University Hospital, MontpellierINSERM 1061, " Neuropsychiatry: epidemiological and clinical research", MontpellierActive, not recruiting
-
University Hospital, GhentCompletedBig Toe ProsthesisBelgium
-
University Hospital, BordeauxNational Cancer Institute (NCI)Completed
-
Zonguldak Bulent Ecevit UniversityCompleteda Survey-based StudyTurkey
-
European University of LefkeCompletedKnowledge, Attitudes, Practice | Nurse's Role | Opioid Use, UnspecifiedTurkey
-
ORIYOMI OMOTOYOSI AKINYOTUUniversity of IbadanCompletedMalaria in Pregnant HIV + PatientsNigeria
-
Centers for Disease Control and PreventionIfakara Health Research and Development CentreCompleted
-
London School of Hygiene and Tropical MedicineKwame Nkrumah University of Science and TechnologyCompletedPregnancy | Malaria | AnaemiaGhana
-
South Valley UniversityIbn Sina Hospital; Qena Fertility Center, Qena, EgyptUnknownImprovement of Embryo Transfer Technique | Improvement of Implantation